On this page
No, you don’t need keto on a GLP-1. Whether it makes sense for you is a question for your clinician, and there’s a good case for starting with something less strict. Semaglutide and tirzepatide already do with medicine what keto tries to do with diet. They make you eat less. Stacking the two stacks the side effects, and there’s no proof it adds to the results.
One lever, pulled twice
GLP-1 medications slow gastric emptying (how fast food leaves your stomach). They also act on the appetite centers in the brain and help your body release insulin. Tirzepatide also acts on a second hormone, called GIP. For most people, that means less hunger, feeling full sooner, and quieter food noise. Whatever else ketosis does, keto takes weight off the same way, because you eat less. Pulling the same lever twice doesn’t move it twice as far. The medication is already suppressing your appetite, so cutting carbs has little left to work on.
The trial numbers didn’t need keto
STEP 1 (Wilding et al., NEJM 2021) tested Wegovy in 1,961 adults with obesity, or overweight plus a weight-related condition, and no diabetes. Brand-name semaglutide (Wegovy) 2.4 mg weekly produced 14.9% average weight loss at 68 weeks, compared with 2.4% on placebo. SURMOUNT-1 (Jastreboff et al., NEJM 2022) tested Zepbound in 2,539 participants. At 72 weeks, brand-name tirzepatide (Zepbound) produced 15.0% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg, compared with 3.1% on placebo. Neither trial put people on a ketogenic diet.
The combination hasn’t been tested. We don’t know of any trial of similar size that put people on strict keto with either drug. So whether it adds anything is truly unknown. What we do know is the cost of each one on its own. Both costs arrive in the same window: the first four months.
The first four months are where stacking hurts
In STEP 1, which tested brand-name semaglutide (Wegovy), nausea was the most common side effect, and it clustered during dose increases. There’s a reason for that. The drug slows gastric emptying. So nausea comes with each dose step and fades as the titration (the gradual dose increase) slows. Standard semaglutide titration takes about four months. You start at 0.25 mg weekly and step up about every 4 weeks through 0.5, 1.0, and 1.7 mg to 2.4 mg. It goes slower if side effects push back.
Adapting to keto happens in the same window. The first weeks of strict carb restriction often bring fatigue, headaches, and lightheadedness. Part of the reason is that emptying your glycogen (stored carbohydrate) sheds water and sodium. Add a slow stomach and lower fluid intake, and constipation can go from a minor note to a side effect that really limits you.
A U.S.-licensed clinician reviews every Zappy case and adjusts the titration. When side effects flare, the fix is a slower dose step, and a stricter diet won’t help.
Spend your appetite on protein
The strongest argument against keto here is body composition. DXA substudies of the GLP-1 trials scanned a subset of participants. They show that a meaningful share of the weight lost is lean mass (mostly muscle) as well as fat. The caveat is that the long-term effects on strength and mobility aren’t well understood yet. The standard countermeasure is resistance training plus 1.2–1.6 g of protein per kilogram of body weight per day.
Here’s the conflict. When your appetite is suppressed, every meal is small. A diet built around fat fills that limited space with the nutrient that does the least to protect muscle. Here’s one common starting point, which your clinician can adjust to you. Put protein first, at the same 1.2–1.6 g/kg. A moderate carb range, such as 50–150 g a day, mostly from vegetables and whole grains, is usually enough to keep workouts manageable. Let fat land where it lands, without fearing it or chasing it. Drink plenty of fluids, because constipation is the real risk of eating lower-carb on a GLP-1.
The exception is lower carb, not keto
Type 2 diabetes, diagnosed insulin resistance, or PCOS changes the target, but the principle stays the same. Your clinician may want you closer to 75–100 g of carbs a day. That’s a moderate cut, and your clinician can check how you’re handling it. The drug already works on blood sugar by improving insulin release, and that weakens the case for cutting carbs any further.
One warning matters a lot. If you take insulin or a sulfonylurea, don’t cut carbs sharply unless your clinician adjusts your doses first. That combination can cause true hypoglycemia (dangerously low blood sugar).
Strict keto, meaning under 30 g of carbs a day, is rarely needed on a GLP-1. That’s our position. What would change it? A randomized trial showing that keto plus a GLP-1 beats the drug alone on fat loss. It would also need the same lean mass retention and no more people dropping out. We know of none.
Pick a diet that lasts as long as the drug
In STEP 4 (Rubino et al., JAMA 2021), people who stopped brand-name semaglutide (Wegovy) at week 20 regained a substantial amount of weight. Those who continued kept it off. SURMOUNT-4 (Aronne et al., JAMA 2024) showed the same thing for Zepbound. After 36 weeks of brand-name tirzepatide (Zepbound), people switched to placebo regained about 14% of their body weight over the next year. Those who stayed on Zepbound lost about 5.5% more. The weight stays off by staying on treatment, so your eating pattern needs to last just as long. A diet you can hold for six weeks is a poor partner for a medication you take for years.
What to do, plainly
- The evidence: People lost 14.9% on average on Wegovy in STEP 1 and up to 20.9% on Zepbound in SURMOUNT-1, with no ketogenic diet involved. Keto on top of the drug hasn’t been tested at scale.
- Standard practice: Eat 1.2–1.6 g/kg/day of protein and do resistance training to protect lean mass. Drink plenty of fluids, and slow the titration when nausea flares.
- Our opinion: Most people don’t need keto. A starting point is 50–150 g of carbs a day from vegetables and whole grains, or closer to 75–100 g if your clinician is managing insulin resistance, type 2 diabetes, or PCOS. Your clinician can adjust this to you, and should review any diabetes medicines first.
The open question is a trial nobody has run. It would randomly assign GLP-1 users to different diets and then measure fat, lean mass, and strength at two years. Until that trial exists, keto on a GLP-1 has a cost and no measured benefit.
